These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22955918)

  • 21. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha.
    Karube K; Ohshima K; Suzumiya J; Kawano R; Kikuchi M; Harada M
    Ann Oncol; 2006 Jan; 17(1):110-6. PubMed ID: 16291580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
    Chetaille B; Bertucci F; Finetti P; Esterni B; Stamatoullas A; Picquenot JM; Copin MC; Morschhauser F; Casasnovas O; Petrella T; Molina T; Vekhoff A; Feugier P; Bouabdallah R; Birnbaum D; Olive D; Xerri L
    Blood; 2009 Mar; 113(12):2765-3775. PubMed ID: 19096012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
    Roemer MGM; Redd RA; Cader FZ; Pak CJ; Abdelrahman S; Ouyang J; Sasse S; Younes A; Fanale M; Santoro A; Zinzani PL; Timmerman J; Collins GP; Ramchandren R; Cohen JB; De Boer JP; Kuruvilla J; Savage KJ; Trneny M; Ansell S; Kato K; Farsaci B; Sumbul A; Armand P; Neuberg DS; Pinkus GS; Ligon AH; Rodig SJ; Shipp MA
    J Clin Oncol; 2018 Apr; 36(10):942-950. PubMed ID: 29394125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.
    Mestre F; Gutierrez A; Ramos R; Martinez-Serra J; Sánchez L; Matheu G; Ros T; Garcia JF; Rodriguez J
    Blood; 2012 Jun; 119(25):6072-9. PubMed ID: 22547578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell-Specific Long Noncoding RNAs.
    Tayari MM; Winkle M; Kortman G; Sietzema J; de Jong D; Terpstra M; Mestdagh P; Kroese FG; Visser L; Diepstra A; Kok K; van den Berg A; Kluiver J
    Am J Pathol; 2016 Sep; 186(9):2462-72. PubMed ID: 27423697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma.
    El Halabi L; Adam J; Gravelle P; Marty V; Danu A; Lazarovici J; Ribrag V; Bosq J; Camara-Clayette V; Laurent C; Ghez D
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):257-266.e3. PubMed ID: 33277223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
    Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma.
    Solórzano JL; Menéndez V; Parra E; Solis L; Salazar R; García-Cosío M; Climent F; Fernández S; Díaz E; Francisco-Cruz A; Khoury J; Jiang M; Tamegnon A; Montalbán C; Melero I; Wistuba I; De Andrea C; F García J
    Oncoimmunology; 2024; 13(1):2388304. PubMed ID: 39135889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene rearrangement and comparative genomic hybridization studies of classic Hodgkin lymphoma expressing T-cell antigens.
    Aguilera NS; Chen J; Bijwaard KE; Director-Myska AE; Barekman CL; Millward C; Lichy J; Abbondanzo SL
    Arch Pathol Lab Med; 2006 Dec; 130(12):1772-9. PubMed ID: 17149949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.
    Joos S; Menz CK; Wrobel G; Siebert R; Gesk S; Ohl S; Mechtersheimer G; Trümper L; Möller P; Lichter P; Barth TF
    Blood; 2002 Feb; 99(4):1381-7. PubMed ID: 11830490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
    Spina V; Bruscaggin A; Cuccaro A; Martini M; Di Trani M; Forestieri G; Manzoni M; Condoluci A; Arribas A; Terzi-Di-Bergamo L; Locatelli SL; Cupelli E; Ceriani L; Moccia AA; Stathis A; Nassi L; Deambrogi C; Diop F; Guidetti F; Cocomazzi A; Annunziata S; Rufini V; Giordano A; Neri A; Boldorini R; Gerber B; Bertoni F; Ghielmini M; Stüssi G; Santoro A; Cavalli F; Zucca E; Larocca LM; Gaidano G; Hohaus S; Carlo-Stella C; Rossi D
    Blood; 2018 May; 131(22):2413-2425. PubMed ID: 29449275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
    Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
    Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin lymphoma: Pathology and biology.
    Mathas S; Hartmann S; Küppers R
    Semin Hematol; 2016 Jul; 53(3):139-47. PubMed ID: 27496304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis.
    Murray PG; Fan Y; Davies G; Ying J; Geng H; Ng KM; Li H; Gao Z; Wei W; Bose S; Anderton J; Kapatai G; Reynolds G; Ito A; Marafioti T; Woodman CB; Ambinder R; Tao Q
    Am J Pathol; 2010 Sep; 177(3):1480-90. PubMed ID: 20709797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma.
    Schwarzer R; Jundt F
    Curr Mol Med; 2011 Apr; 11(3):236-45. PubMed ID: 21375490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?
    Bellan C; Lazzi S; Zazzi M; Lalinga AV; Palummo N; Galieni P; Marafioti T; Tonini T; Cinti C; Leoncini L; Pileri SA; Tosi P
    Diagn Mol Pathol; 2002 Mar; 11(1):2-8. PubMed ID: 11854595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.